Olivia J. Phung, PharmD

Articles

Golimumab: A human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseases

September 01, 2009

Golimumab is a human anti-tumor necrosis factor (TNF)-alpha monoclonal antibody that was recently approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.